IBB

Fund Description
The iShares Nasdaq Biotechnology Index Fund seeks investment results that correspond generally to the price and yield performance before fees and expenses of companies primarily engaged in the biotechnology industry as represented by the NASDAQ Biotechnology Index .
Fund Profile
Fund Name iShares Nasdaq Biotechnology ETF
Fund Exchange Ticker IBB
Fund Sponsor Blackrock (iShares)
Fund ISIN US4642875565
Net Expense Ratio 0.47 %
Fund Inception Date 5 February 2001
Fund Legal Structure ETF (Open end fund)
Exchange NASDAQ
Listing Country Code US
Fund Investment Objective
ETF Type Specific US Equities - Industry Sector
Asset Class Equities (Stocks)
Index Linked Passive
Index Name NASDAQ Biotechnology Index
Index Provider Nasdaq
Currency Hedged No
Inverse / Leveraged Not Applicable
Developed / Emerging Developed Market Funds
Market Capitalization Range Broad Market / Multi-Cap
Growth Value Core / Blend
Continent North America
Key Statistics
Return As of Date 22 March 2019
Asset Under Management 8109.59 Million (USD)
1 Month Total Return -0.90 %
Year To Date Return 12.17 %
1 Year Total Return -2.09 %
3 Year Annualized Total Return 8.40 %
NAV 108.2
Share Outstanding 74,950,000
Top 10 Holdings (21 March 2019)
Constituent Name Constituent Ticker Constituent Type Weighting
AMGEN INC AMGN EQUI 0.0813000000
GILEAD SCIENCES INC GILD EQUI 0.0804000000
CELGENE CORP CELG EQUI 0.0770000000
VERTEX PHARMACEUTICALS INC VRTX EQUI 0.0571000000
BIOGEN INC BIIB EQUI 0.0546000000
ILLUMINA INC ILMN EQUI 0.0411000000
ALEXION PHARMACEUTICALS INC ALXN EQUI 0.0389000000
REGENERON PHARMACEUTICALS REGN EQUI 0.0376000000
INCYTE CORP INCY EQUI 0.0242000000
BIOMARIN PHARMACEUTICAL INC BMRN EQUI 0.0210000000